Australia's largest stock trading and investment forum Australia's #1 stock forum

SPL

Click for more information

1.12%

9.0¢ starpharma holdings limited

DEP Phase 3 trials no certainty, page-9

First 9 Last

Share
Profile

Follow
col69

15,398 Posts.

5514

24/05/24

10:12

Post #: 73988805
Share

Originally posted by col69 ↑

But @sarge17 we have been told constantly by JF and Starpharma ( and @antibotter) that we didn't need phase 3 trials .... we were a shoe in for the FDA Section 505 (b) [2] application for our DEP in house trialed drugs ..... supposedly so easy for any of the big pharmas to do and yet they're still not interested ? lol

Post #:66584800

As previously stated by Starpharma in announcements over the years, once phase 2 of the three in house trials have been completed and licensed out to a tier 1 pharma, a 505(b)(2) application may be made to the regulatory authorities to bypass phase 3 clinical trials and bring straight to market our Dep Docetaxel, Dep Cabazitaxel, and Dep Irinotecan

Post #:66588151

Based on the a 505(b)(2) application scenario being successful, tier 1 pharma would spend absolutely nothing on Phase 3 trials.

Expand

Perhaps the new CEO is buying today now that the Webinar is done and dusted and the decks have been cleared ? Huge demand upon the market opening - 1 share / 1 trade for 11.5 cents ? That would almost be a record on the ASX (and not a good one) lol

SPL Price at posting: 11.5¢ Sentiment: None Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

Eurozone-based companies find new ways to secure a regional lithium supply

End of FY is a time to juggle wins, losses and capital gains taxes

ASX200 dives as inflation clocks in at 4% – higher than 3.8% consensus

SS1

Sun Silver submits US$60M Silver Paste Funding Application to US DoE

Time for retail therapy buying in the shopping Scentre for hot stocks

There are more pages in this discussion • 3 more messages in this thread...

First 9 Last

Add SPL (ASX) to my watchlist

(20min delay)
Last 9.0¢		Change 0.001(1.12%)		Mkt cap ! $37.08M

Open	High	Low	Value	Volume
9.0¢	9.1¢	8.8¢	$99.71K	1.111M

Buyers (Bids)

No.	Vol.	Price($)
3	59562	9.0¢

Sellers (Offers)

Price($)	Vol.	No.
9.1¢	55591	3

View Market Depth

No.	Vol.	Price($)
4	104467	0.090
2	296833	0.089
1	7773	0.088
1	100000	0.087
3	119243	0.086

Price($)	Vol.	No.
0.091	74703	2
0.092	80903	3
0.093	25584	4
0.095	28035	3
0.096	7000	2

Last trade - 13.07pm 26/06/2024 (20 minute delay)

SPL (ASX) Chart